New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo
Authors:
Open Access
- 20 January 2005
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 12 (6) , 504-511
Abstract
Regulation of transgene expression is a major goal of gene therapy research. Previously, we have developed a complex adenovirus (Ad) vector with tetracycline-regulated expression of a Fas ligand (FasL)-green fluorescent protein (GFP) fusion protein. This vector delivered high levels of activity that was regulated by doxycycline. However, this regulation was limited by the low but significant background activity of the TRE promoter. Recently, the Tet-regulated transcriptional silencer, tTS, was reported to suppress efficiently basal TRE activity without affecting induced expression levels. Here, we report development of Ad vectors that incorporate tTS in combination with that of reverse transactivator (rtTA) coupled with TRE promoter driving transgene expression. Incorporation of tTS improved control of transgene expression in vitro, so that an induction range of over three orders of magnitude was achieved in some cell lines. Effective regulation of transgene expression was also seen in a mouse model in vivo, following systemic vector delivery. In the case of FasL-GFP expression, significant improvement in the control of apoptotic activity both in vitro and in a mouse hepatotoxicity model was demonstrated when using rtTA-tTS vectors. In conclusion, a highly effective transgene regulation system, deliverable by a single adenoviral vector, is now available.Keywords
This publication has 30 references indexed in Scilit:
- The tet‐off system is more effective than the tet‐on system for regulating transgene expression in a single adenovirus vectorThe Journal of Gene Medicine, 2002
- Intracellular Fas Ligand Expression Causes Fas-Mediated Apoptosis in Human Prostate Cancer Cells Resistant to Monoclonal Antibody-Induced ApoptosisMolecular Therapy, 2000
- Regulatable systems: applications in gene therapy and replicating virusesJournal of Clinical Investigation, 2000
- Adenoviral vector which delivers FasL–GFP fusion protein regulated by the tet-inducible expression systemGene Therapy, 2000
- Fas Ligand-Induced ApoptosisAnnual Review of Genetics, 1999
- Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouseCancer Gene Therapy, 1999
- Transgene Expression in Malignant Glioma Using a Replication-Defective Adenoviral Vector Containing the Egr-1 Promoter: Activation by Ionizing Radiation or Uptake of Radioactive IododeoxyuridineHuman Gene Therapy, 1998
- Generation of Recombinant Adenovirus Vector with Infectious Adenoviral Genome Released from Cosmid-Based Vector by Simple Procedure Allowing Complex ManipulationBiochemical and Biophysical Research Communications, 1998
- Human Fas ligand: gene structure, chromosomal location and species specificityInternational Immunology, 1994
- Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elementsTrends in Biochemical Sciences, 1993